National Venture Capital Association

Devices & Diagnostics

Life sciences investment shifting to Europe, Asia

Venture capital investment in the life sciences has fallen 39 percent over the past three years as the costly, lengthy process of getting  approval for pharmaceuticals from the Food and Drug Administration has spurred companies to shift their investments to overseas markets in Europe and Asia. According to the survey of 150 venture capital firms,  […]


Morning Read: What do May venture dollar flurries bring?

Highlights of the important and the interesting from the world of healthcare: May ends with flurry of new venture dollars: Medtronic (NYSE: MDT) made the biggest investment during the month, putting $70 million in Israeli medical device company BioControl Medical. Also receiving fresh cash: Boston-based Tesaro secured $60 million in start-up funding; NOXXON Pharma of […]


Yes, Minnesota, it does and can get worse

I’ve been covering Minnesota venture capital for the past three years. Which means I’ve run out of words to describe how bad the state’s venture capital climate has become. So I’ll just let the numbers speak for themselves. Four Minnesota companies received only $20.1 million in venture capital during the first three months of the […]


Morning Read: Ugly first quarter for venture capital

Highlights of the important and the interesting from the world of healthcare: Ugly first quarter for VCs: The venture capital industry continues to undergo convulsive change, as first-quarter fundraising hit its lowest point since 1993, according to the National Venture Capital Association. Fundraising fell 31 percent to $3.6 billion when compared to last year’s first […]